|
March 24, 2023 |
March 24, 2023 |
B
Purchase
|
Eisenstadt Richard I
Chief Financial Officer
Officer
|
10,000
+83.3%
4.31
43,140
USD
|
10,000
+83.3%
|
4.31
|
43,140
USD
|
|
|
March 27, 2023 |
March 23, 2023 |
B
Purchase
|
Drutz David
Non-Executive Director
|
9,000
+43.9%
4.27
38,430
USD
|
9,000
+43.9%
|
4.27
|
38,430
USD
|
|
|
March 23, 2023 |
March 23, 2023 |
B
Purchase
|
Harris Matthew Scott
Chief Medical Officer
Officer
|
10,000
+42.9%
4.22
42,200
USD
|
10,000
+42.9%
|
4.22
|
42,200
USD
|
|
|
Dec. 22, 2022 |
Dec. 22, 2022 |
PS
Planned sale
|
Pisano Wayne
Non-Executive Director
|
20,000
-70.2%
15.01
300,268
USD
|
20,000
-70.2%
|
15.01
|
300,268
USD
|
|
|
Sept. 1, 2022 |
Aug. 31, 2022 |
PS
Planned sale
|
Garg Vipin K
President and CEO
Executive Director
|
20,000
-7.8%
20.02
400,322
USD
|
20,000
-7.8%
|
20.02
|
400,322
USD
|
|
|
Aug. 12, 2022 |
Aug. 12, 2022 |
PS
Planned sale
|
Garg Vipin K
President and CEO
Executive Director
|
15,000
-5.5%
15.06
225,890
USD
|
15,000
-5.5%
|
15.06
|
225,890
USD
|
|
|
July 5, 2022 |
July 5, 2022 |
PS
Planned sale
|
Roberts M Scot
Chief Scientific Officer
Officer
|
10,182
-55.1%
12.00
122,184
USD
|
10,182
-55.1%
|
12.00
|
122,184
USD
|
|
|
July 5, 2022 |
July 1, 2022 |
PS
Planned sale
|
Roberts M Scot
Chief Scientific Officer
Officer
|
26,982
-60.4%
12.00
323,784
USD
|
26,982
-60.4%
|
12.00
|
323,784
USD
|
|
|
June 28, 2022 |
June 27, 2022 |
PS
Planned sale
|
Roberts M Scot
Chief Scientific Officer
Officer
|
37,352
-67.8%
12.00
448,254
USD
|
37,352
-67.8%
|
12.00
|
448,254
USD
|
|
|
June 28, 2022 |
June 27, 2022 |
PS
Planned sale
|
Jorkasky Diane
Non-Executive Director
|
17,610
-100.0%
11.75
206,944
USD
|
17,610
-100.0%
|
11.75
|
206,944
USD
|
|
|
June 16, 2022 |
June 15, 2022 |
B
Purchase
|
Drutz David
Non-Executive Director
|
1,000
+5.3%
8.00
8,000
USD
|
1,000
+5.3%
|
8.00
|
8,000
USD
|
|
|
May 25, 2022 |
May 24, 2022 |
B
Purchase
|
Drutz David
Non-Executive Director
|
1,200
+6.7%
4.50
5,400
USD
|
1,200
+6.7%
|
4.50
|
5,400
USD
|
|
|
March 2, 2022 |
Feb. 28, 2022 |
PS
Planned sale
|
Harris Matthew Scott
Chief Medical Officer
Officer
|
30,000
-72.2%
7.52
225,600
USD
|
30,000
-72.2%
|
7.52
|
225,600
USD
|
|
|
March 1, 2021 |
March 1, 2021 |
PS
Planned sale
|
Hodges Philip
Non-Executive Director
|
6,000
-40.7%
16.08
96,480
USD
|
6,000
-40.7%
|
16.08
|
96,480
USD
|
|
|
Dec. 11, 2020 |
Dec. 10, 2020 |
B
Purchase
|
Schafer Klaus
Non-Executive Director
|
2,000
+29.0%
11.99
23,980
USD
|
2,000
+29.0%
|
11.99
|
23,980
USD
|
|
|
Dec. 2, 2020 |
Dec. 1, 2020 |
PS
Planned sale
|
Hodges Philip
Non-Executive Director
|
1,227
-100.0%
13.54
16,614
USD
|
1,227
-100.0%
|
13.54
|
16,614
USD
|
|
|
Dec. 2, 2020 |
Nov. 30, 2020 |
PS
Planned sale
|
GILL JOHN
Non-Executive Director
|
8,425
-42.9%
11.92
100,426
USD
|
8,425
-42.9%
|
11.92
|
100,426
USD
|
|
|
Dec. 2, 2020 |
Nov. 30, 2020 |
PS
Planned sale
|
Hodges Philip
Non-Executive Director
|
2,500
-14.5%
12.00
30,000
USD
|
2,500
-14.5%
|
12.00
|
30,000
USD
|
|
|
Nov. 13, 2020 |
Nov. 12, 2020 |
PS
Planned sale
|
Schafer Klaus
Non-Executive Director
|
10,150
-59.5%
9.91
100,587
USD
|
10,150
-59.5%
|
9.91
|
100,587
USD
|
|
|
Nov. 13, 2020 |
Nov. 12, 2020 |
PS
Planned sale
|
Pisano Wayne
Non-Executive Director
|
10,352
-54.9%
9.90
102,485
USD
|
10,352
-54.9%
|
9.90
|
102,485
USD
|
|
|
Nov. 13, 2020 |
Nov. 12, 2020 |
PS
Planned sale
|
Harris Matthew Scott
Non-Executive Director
|
4,015
-49.7%
10.02
40,230
USD
|
4,015
-49.7%
|
10.02
|
40,230
USD
|
|
|
June 15, 2020 |
June 15, 2020 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Major owner
|
1,500,000
+50.0%
7.54
11,310,000
USD
|
1,500,000
+50.0%
|
7.54
|
11,310,000
USD
|
|
|
May 28, 2020 |
May 28, 2020 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Major owner
|
173,711
+6.1%
8.87
1,540,817
USD
|
173,711
+6.1%
|
8.87
|
1,540,817
USD
|
|
|
May 28, 2020 |
May 28, 2020 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Major owner
|
27,763
+1.0%
7.79
216,274
USD
|
27,763
+1.0%
|
7.79
|
216,274
USD
|
|
|
May 28, 2020 |
May 27, 2020 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Major owner
|
277,000
+11.0%
7.92
2,193,840
USD
|
277,000
+11.0%
|
7.92
|
2,193,840
USD
|
|
|
May 28, 2020 |
May 27, 2020 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Major owner
|
125,162
+5.2%
7.23
904,921
USD
|
125,162
+5.2%
|
7.23
|
904,921
USD
|
|
|
May 28, 2020 |
May 26, 2020 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Major owner
|
390,547
+19.5%
9.78
3,819,550
USD
|
390,547
+19.5%
|
9.78
|
3,819,550
USD
|
|
|
May 28, 2020 |
May 26, 2020 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Major owner
|
309,453
+18.2%
8.79
2,720,092
USD
|
309,453
+18.2%
|
8.79
|
2,720,092
USD
|
|
|
May 18, 2020 |
May 15, 2020 |
S
Sale
|
VELOCITY PHARMACEUTICAL HOLDINGS LLC
Major owner
|
30,622
-1.8%
4.65
142,392
USD
|
30,622
-1.8%
|
4.65
|
142,392
USD
|
|
|
May 18, 2020 |
May 14, 2020 |
S
Sale
|
VELOCITY PHARMACEUTICAL HOLDINGS LLC
Major owner
|
169,378
-9.0%
4.81
814,708
USD
|
169,378
-9.0%
|
4.81
|
814,708
USD
|
|
|
Sept. 5, 2019 |
Sept. 5, 2019 |
B
Purchase
|
Garg Vipin K
President and CEO
Executive Director
|
20,000
+6.2%
2.10
42,000
USD
|
20,000
+6.2%
|
2.10
|
42,000
USD
|
|
|
Oct. 11, 2018 |
Oct. 9, 2018 |
B
Purchase
|
Pisano Wayne
Non-Executive Director
|
2,000
+inf%
4.59
9,180
USD
|
2,000
+inf%
|
4.59
|
9,180
USD
|
|
|
May 29, 2018 |
May 25, 2018 |
B
Purchase
|
Enright William
President and CEO
Executive Director
|
1,300
+0.4%
0.51
660
USD
|
1,300
+0.4%
|
0.51
|
660
USD
|
|
|
Jan. 3, 2018 |
Dec. 29, 2017 |
B
Purchase
|
SAYARE MITCHEL
Non-Executive Director
|
5,100
+18.5%
1.95
9,963
USD
|
5,100
+18.5%
|
1.95
|
9,963
USD
|
|
|
Jan. 2, 2018 |
Dec. 29, 2017 |
B
Purchase
|
SCHAFFER DERACE L
Non-Executive Director
|
38,699
+7.0%
1.93
74,778
USD
|
38,699
+7.0%
|
1.93
|
74,778
USD
|
|
|
Jan. 2, 2018 |
Dec. 28, 2017 |
B
Purchase
|
SCHAFFER DERACE L
Non-Executive Director
|
58,711
+11.9%
1.92
112,672
USD
|
58,711
+11.9%
|
1.92
|
112,672
USD
|
|
|
Dec. 27, 2017 |
Dec. 27, 2017 |
B
Purchase
|
SCHAFFER DERACE L
|
27,706
+6.0%
1.77
49,040
USD
|
27,706
+6.0%
|
1.77
|
49,040
USD
|
|
|
Dec. 27, 2017 |
Dec. 27, 2017 |
B
Purchase
|
SCHAFFER DERACE L
|
50,000
+12.1%
1.76
88,170
USD
|
50,000
+12.1%
|
1.76
|
88,170
USD
|
|
|
Dec. 27, 2017 |
Dec. 26, 2017 |
B
Purchase
|
SCHAFFER DERACE L
|
51,442
+14.2%
1.81
93,269
USD
|
51,442
+14.2%
|
1.81
|
93,269
USD
|
|
|
Dec. 27, 2017 |
Dec. 22, 2017 |
B
Purchase
|
SCHAFFER DERACE L
|
17,982
+5.2%
1.61
28,877
USD
|
17,982
+5.2%
|
1.61
|
28,877
USD
|
|
|
Dec. 8, 2017 |
Dec. 7, 2017 |
B
Purchase
|
SCHAFFER DERACE L
|
7,639
+2.3%
1.74
13,308
USD
|
7,639
+2.3%
|
1.74
|
13,308
USD
|
|
|
Dec. 8, 2017 |
Dec. 6, 2017 |
B
Purchase
|
SCHAFFER DERACE L
|
16,106
+5.0%
1.80
28,996
USD
|
16,106
+5.0%
|
1.80
|
28,996
USD
|
|
|
Dec. 5, 2017 |
Dec. 5, 2017 |
B
Purchase
|
SCHAFFER DERACE L
|
13,495
+4.4%
1.78
23,987
USD
|
13,495
+4.4%
|
1.78
|
23,987
USD
|
|
|
Dec. 5, 2017 |
Dec. 4, 2017 |
B
Purchase
|
SCHAFFER DERACE L
|
7,300
+2.4%
1.81
13,195
USD
|
7,300
+2.4%
|
1.81
|
13,195
USD
|
|
|
Dec. 5, 2017 |
Dec. 1, 2017 |
B
Purchase
|
SCHAFFER DERACE L
|
5,215
+1.8%
1.80
9,405
USD
|
5,215
+1.8%
|
1.80
|
9,405
USD
|
|
|
Nov. 30, 2017 |
Nov. 30, 2017 |
B
Purchase
|
SCHAFFER DERACE L
|
12,978
+4.6%
1.84
23,816
USD
|
12,978
+4.6%
|
1.84
|
23,816
USD
|
|
|
Nov. 30, 2017 |
Nov. 29, 2017 |
B
Purchase
|
SCHAFFER DERACE L
|
7,942
+2.9%
1.94
15,377
USD
|
7,942
+2.9%
|
1.94
|
15,377
USD
|
|
|
Nov. 30, 2017 |
Nov. 28, 2017 |
B
Purchase
|
SCHAFFER DERACE L
|
12,395
+4.7%
1.97
24,445
USD
|
12,395
+4.7%
|
1.97
|
24,445
USD
|
|
|
Nov. 27, 2017 |
Nov. 27, 2017 |
B
Purchase
|
SCHAFFER DERACE L
|
10,042
+4.0%
2.00
20,060
USD
|
10,042
+4.0%
|
2.00
|
20,060
USD
|
|
|
Nov. 27, 2017 |
Nov. 24, 2017 |
B
Purchase
|
SCHAFFER DERACE L
|
6,505
+2.7%
2.02
13,162
USD
|
6,505
+2.7%
|
2.02
|
13,162
USD
|
|
|
Nov. 27, 2017 |
Nov. 22, 2017 |
B
Purchase
|
SCHAFFER DERACE L
|
5,261
+2.2%
2.10
11,061
USD
|
5,261
+2.2%
|
2.10
|
11,061
USD
|
|
|
Nov. 21, 2017 |
Nov. 21, 2017 |
B
Purchase
|
SCHAFFER DERACE L
|
7,236
+3.1%
2.06
14,905
USD
|
7,236
+3.1%
|
2.06
|
14,905
USD
|
|
|
Nov. 21, 2017 |
Nov. 20, 2017 |
B
Purchase
|
SCHAFFER DERACE L
|
4,800
+2.1%
2.07
9,958
USD
|
4,800
+2.1%
|
2.07
|
9,958
USD
|
|
|
Nov. 21, 2017 |
Nov. 17, 2017 |
B
Purchase
|
SCHAFFER DERACE L
|
6,295
+2.8%
2.12
13,352
USD
|
6,295
+2.8%
|
2.12
|
13,352
USD
|
|
|
Aug. 28, 2017 |
Aug. 25, 2017 |
B
Purchase
|
SCHAFFER DERACE L
|
50,000
+29.1%
2.25
112,390
USD
|
50,000
+29.1%
|
2.25
|
112,390
USD
|
|
|
Aug. 28, 2017 |
Aug. 24, 2017 |
B
Purchase
|
SCHAFFER DERACE L
|
17,326
+11.2%
2.24
38,892
USD
|
17,326
+11.2%
|
2.24
|
38,892
USD
|
|
|
Aug. 24, 2017 |
Aug. 23, 2017 |
B
Purchase
|
Drutz David
|
5,000
+19.4%
2.27
11,340
USD
|
5,000
+19.4%
|
2.27
|
11,340
USD
|
|
|
Aug. 23, 2017 |
Aug. 23, 2017 |
B
Purchase
|
SCHAFFER DERACE L
|
43,352
+39.0%
2.22
96,350
USD
|
43,352
+39.0%
|
2.22
|
96,350
USD
|
|
|
Aug. 24, 2017 |
Aug. 22, 2017 |
B
Purchase
|
Drutz David
|
5,000
+24.1%
2.15
10,758
USD
|
5,000
+24.1%
|
2.15
|
10,758
USD
|
|
|
Aug. 23, 2017 |
Aug. 22, 2017 |
B
Purchase
|
SCHAFFER DERACE L
|
5,958
+5.7%
2.10
12,519
USD
|
5,958
+5.7%
|
2.10
|
12,519
USD
|
|
|
Aug. 23, 2017 |
Aug. 21, 2017 |
B
Purchase
|
SCHAFFER DERACE L
|
690
+0.7%
2.02
1,395
USD
|
690
+0.7%
|
2.02
|
1,395
USD
|
|
|
Feb. 23, 2018 |
June 6, 2017 |
B
Purchase
|
Roberts M Scot
Chief Scientific Officer
Officer
|
449
+inf%
4.42
1,985
USD
|
449
+inf%
|
4.42
|
1,985
USD
|
|
|
June 6, 2017 |
June 2, 2017 |
B
Purchase
|
GILL JOHN
|
1,000
+1.2%
4.34
4,344
USD
|
1,000
+1.2%
|
4.34
|
4,344
USD
|
|
|
Dec. 9, 2016 |
Dec. 9, 2016 |
S
Sale
|
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
Major owner
|
436,324
-6.2%
3.26
1,422,416
USD
|
436,324
-6.2%
|
3.26
|
1,422,416
USD
|
|
|
Dec. 9, 2016 |
Dec. 8, 2016 |
S
Sale
|
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
Major owner
|
440,479
-5.9%
3.25
1,431,557
USD
|
440,479
-5.9%
|
3.25
|
1,431,557
USD
|
|
|
Dec. 9, 2016 |
Dec. 7, 2016 |
S
Sale
|
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
Major owner
|
477,829
-6.0%
3.26
1,557,723
USD
|
477,829
-6.0%
|
3.26
|
1,557,723
USD
|
|
|
April 15, 2016 |
April 13, 2016 |
PS
Planned sale
|
RICHMAN ERIC I
Non-Executive Director
|
75,000
-29.8%
2.20
165,000
USD
|
75,000
-29.8%
|
2.20
|
165,000
USD
|
|
|
April 15, 2016 |
April 13, 2016 |
PS
Planned sale
|
RICHMAN ERIC I
Non-Executive Director
|
91,121
-34.0%
2.20
200,466
USD
|
91,121
-34.0%
|
2.20
|
200,466
USD
|
|
|
April 15, 2016 |
April 13, 2016 |
PS
Planned sale
|
RICHMAN ERIC I
Non-Executive Director
|
150,000
-45.9%
2.20
330,000
USD
|
150,000
-45.9%
|
2.20
|
330,000
USD
|
|
|
April 15, 2016 |
April 13, 2016 |
PS
Planned sale
|
RICHMAN ERIC I
Non-Executive Director
|
13,233
-7.0%
2.20
29,113
USD
|
13,233
-7.0%
|
2.20
|
29,113
USD
|
|
|
April 11, 2016 |
April 8, 2016 |
PS
Planned sale
|
RICHMAN ERIC I
Non-Executive Director
|
6,400
-3.5%
2.20
14,080
USD
|
6,400
-3.5%
|
2.20
|
14,080
USD
|
|
|
April 11, 2016 |
April 7, 2016 |
PS
Planned sale
|
RICHMAN ERIC I
Non-Executive Director
|
5,367
-2.9%
2.20
11,807
USD
|
5,367
-2.9%
|
2.20
|
11,807
USD
|
|
|
March 23, 2015 |
March 19, 2015 |
B
Purchase
|
St Peter Steven
Non-Executive Director
|
25,000
+inf%
1.65
41,213
USD
|
25,000
+inf%
|
1.65
|
41,213
USD
|
|
|
Jan. 9, 2015 |
Jan. 7, 2015 |
PS
Planned sale
|
CHANG LINDA L
SVP, CFO & Secretary
Officer
|
29,600
-49.7%
2.10
62,160
USD
|
29,600
-49.7%
|
2.10
|
62,160
USD
|
|
|
Sept. 24, 2014 |
Sept. 22, 2014 |
B
Purchase
|
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
Major owner
|
8,500
+0.1%
1.55
13,175
USD
|
8,500
+0.1%
|
1.55
|
13,175
USD
|
|
